Sarah Ellson co-leads the firm’s regulatory group and specialises in healthcare regulation. She acts for numerous regulators, many of which cover disciplines at the frontiers of medical science, such as the Human Fertilisation and Embryology Authority, for whom Sarah has advised on new mitochondrial donation regulation and licensing and the authorisation of gene editing in research. With the Human Tissue Authority, Sarah has advised on aspects of living and post-mortem organ donation and DNA preservation. She has worked with health and social care regulators, including the General Medical Council, the Nursing and Midwifery Council, the General Dental Council and the Northern Ireland and Scottish Social Care Councils, as well as those educating healthcare students.
She increasingly works for the private sector supporting numerous and diverse private providers and investors in the pharmaceutical, optical, pharmacy, fertility, audiology, dentistry, psychology and blood-banking sectors and supports new healthcare clients looking to enter the English market. She has advised on the Coronavirus Regulations and has supported clients and where necessary challenged regulators during the pandemic.
The Healthcare Law Review provides a global introduction to healthcare economies and their legal frameworks. It covers both diverse areas of practice and the common challenges and approaches across key jurisdictions, including the role of insurance or public payers; models of commissioning; the interplay between primary, secondary and social care; and the regulatory and licensing arrangements for healthcare providers and professionals.